Hereditary Coproporphyria (HCP): Clinical Trials

3 trials for Hereditary Coproporphyria (HCP), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Hereditary Coproporphyria (HCP): new trials by email Literature Review of Hereditary Coproporphyria (HCP) trials Research Report on Hereditary Coproporphyria (HCP)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Acute Hepatic Porphyria, Hepatic Porphyrias
TerminatedAlnylam Pharmaceuticals2122018-05-292019-01-25
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
Givosiran, Placebo - Acute Hepatic Porphyria, Acute Intermittent Porphyria
Phase 3CompletedAlnylam Pharmaceuticals942017-11-162024-04-22
Clinical Diagnosis of Acute Porphyria
Hereditary Coproporphyria (HCP), Acute Intermittent Porphyria (AIP)
CompletedUniversity of California, San Francisco1482011-12-012021-09-28

Narrower conditions

Coproporphyria, Hereditary (3)  ·  Porphyria, Acute Intermittent (3)  ·  Porphyria, Variegate (3)  ·  Porphyrias (1)  ·  Porphyrias, Hepatic (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Digestive System Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Liver Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Genetic (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Porphyrias (2)  ·  Porphyrias, Hepatic (2)

Interventions

givosiran (1)

Sponsors

Alnylam Pharmaceuticals (2)  ·  University of California, San Francisco (1)

Countries

United States (3)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Bruce Wang, M.D. (1)  ·  Herbert L. Bonkovsky, M.D. (1)  ·  James P. Kushner, M.D. (1)  ·  Joseph R. Bloomer, M.D. (1)  ·  Karl E. Anderson, M.D. (1)  ·  Quinn Dinh, MD (1)  ·  Robert J. Desnick, Ph.D., M.D. (1)

Results publications

PMID 32521132, PMID 36028858, PMID 37479139, PMID 38044204, PMID 41388232

NIH funding

U54DK083909 (1)